Gene · 2925
Papers2,036
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
361 to 380 of 2,036
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Searching for a Paradigm Shift in Auger-Electron Cancer Therapy with Tumor-Specific Radiopeptides Targeting the Mitochondria and/or the Cell Nucleus. | Int J Mol Sci | 2022 | 35806239 | PubTator, text mining | PubMed |
| Examination of Charge Modifications of an Endolysosomal Trapping Inhibitor in an Antagonistic NTSR1-Targeted Construct for Colon Cancer. | Bioconjug Chem | 2022 | 35793523 | PubTator, text mining | PubMed |
| A novel pathogenetic factor of laryngeal attack in hereditary angioedema? Involvement of protease activated receptor 1. | Allergy Asthma Clin Immunol | 2022 | 35787812 | PubTator, text mining | PubMed |
| Copper-67-Labeled Bombesin Peptide for Targeted Radionuclide Therapy of Prostate Cancer. | Pharmaceuticals (Basel) | 2022 | 35745647 | PubTator, text mining | PubMed |
| 68Ga-Labeled [Leu13ψThz14]Bombesin(7-14) Derivatives: Promising GRPR-Targeting PET Tracers with Low Pancreas Uptake. | Molecules | 2022 | 35744904 | PubTator, text mining | PubMed |
| PET Imaging of the Neuropeptide Y System: A Systematic Review. | Molecules | 2022 | 35744852 | PubTator, text mining | PubMed |
| TAPBPR employs a ligand-independent docking mechanism to chaperone MR1 molecules. | Nat Chem Biol | 2022 | 35725941 | PubTator, text mining | PubMed |
| The Value of Multimodality PET/CT Imaging in Detecting Prostate Cancer Biochemical Recurrence. | Front Endocrinol (Lausanne) | 2022 | 35712249 | PubTator, text mining | PubMed |
| Metal Peptide Conjugates in Cell and Tissue Imaging and Biosensing. | Top Curr Chem (Cham) | 2022 | 35701677 | PubTator, text mining | PubMed |
| Characterization of the expression of gastrin-releasing peptide and its receptor in the trigeminal and spinal somatosensory systems of Japanese macaque monkeys: Insight into humans. | J Comp Neurol | 2022 | 35686563 | PubTator, text mining | PubMed |
| GRPr Theranostics: Current Status of Imaging and Therapy using GRPr Targeting Radiopharmaceuticals. | Nuklearmedizin | 2022 | 35668669 | PubTator, text mining | PubMed |
| Bioconjugated chelates based on (methylpyridinyl)tacn: synthesis, 64Cu labeling and in vitro evaluation for prostate cancer targeting. | Metallomics | 2022 | 35648482 | PubTator, text mining | PubMed |
| Determinants of trafficking, conduction, and disease within a K+ channel revealed through multiparametric deep mutational scanning. | Elife | 2022 | 35639599 | PubTator, text mining | PubMed |
| Design, Synthesis, and Evaluation of Linker-Optimised PSMA-Targeting Radioligands. | Pharmaceutics | 2022 | 35631684 | PubTator, text mining | PubMed |
| Persistent Properties of a Subpopulation of Cancer Cells Overexpressing the Hedgehog Receptor Patched. | Pharmaceutics | 2022 | 35631574 | PubTator, text mining | PubMed |
| Effect of Statins on Lung Cancer Molecular Pathways: A Possible Therapeutic Role. | Pharmaceuticals (Basel) | 2022 | 35631415 | PubTator, text mining | PubMed |
| Porphyrins as Chelating Agents for Molecular Imaging in Nuclear Medicine. | Molecules | 2022 | 35630788 | PubTator, text mining | PubMed |
| The Chemical Scaffold of Theranostic Radiopharmaceuticals: Radionuclide, Bifunctional Chelator, and Pharmacokinetics Modifying Linker. | Molecules | 2022 | 35630536 | PubTator, text mining | PubMed |
| Using GPCRs as Molecular Beacons to Target Ovarian Cancer with Nanomedicines. | Cancers (Basel) | 2022 | 35625966 | PubTator, text mining | PubMed |
| Short and long-term effect of dexamethasone on the transcriptome profile of primary human trabecular meshwork cells in vitro. | Sci Rep | 2022 | 35585182 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2925/papers?page=19